Receptor News and Research

RSS
Single infusion of engineered T-cells achieves lasting asthma remission in mice

Single infusion of engineered T-cells achieves lasting asthma remission in mice

Study may facilitate the development of new personalized treatments for schizophrenia                                                       An International Study Publi...

Study may facilitate the development of new personalized treatments for schizophrenia An International Study Publi...

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

Targeting Ctdnep1: A potential therapeutic approach to combat bone loss

Study reveals sex-specific cognitive effects of astrocytic receptors

Study reveals sex-specific cognitive effects of astrocytic receptors

How tight binding between immune cells dictates T cell cancer-fighting ability

How tight binding between immune cells dictates T cell cancer-fighting ability

Newly discovered lincRNA controls the development and function of regulatory T cells

Newly discovered lincRNA controls the development and function of regulatory T cells

Female and male heart failure may require distinct treatments

Female and male heart failure may require distinct treatments

Exercise-induced exerkines: Secret weapon in disease prevention and therapy

Exercise-induced exerkines: Secret weapon in disease prevention and therapy

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

Oral semaglutide shows significant promise in improving diabetes control and cardiovascular health, study reveals

Opioid receptors play unexpected role in gut nervous system development

Opioid receptors play unexpected role in gut nervous system development

New antibody shows promise as universal weapon against COVID-19 variants

New antibody shows promise as universal weapon against COVID-19 variants

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

GLP-1 receptor agonists effective for weight loss in obesity without diabetes

Study finds Plexin-B1 could be key to Alzheimer’s treatment, enhancing glial cell response

Study finds Plexin-B1 could be key to Alzheimer’s treatment, enhancing glial cell response

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

SELECT trial shows semaglutide reduces kidney decline in obese patients

SELECT trial shows semaglutide reduces kidney decline in obese patients

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

Immunotherapy-chemotherapy combo boosts survival for patients with metastatic colorectal cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.